Nestle to buy Aimmune, valuing allergy treatment maker at $2.6 billion
Nestle said it was offering $34.50 per share for the remaining 74.4% in peanut allergy treatment maker Aimmune Therapeutics31-08-2020
Nestle to buy Aimmune, valuing allergy treatment maker at $2.6 billion
Nestle said it was offering $34.50 per share for the remaining 74.4% in peanut allergy treatment maker Aimmune TherapeuticsNestle: Stock offers good opportunity for medium to long-term investors
Strong resilient portfolio, along with recent ready-to-eat launches and focus on rural distribution, indicate good growth potentialNESTLE INDIA LTD. - 500790 - Disclosure Of Related Party Transactions As Required Under Regulation 23(9) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
The Company has submitted disclosure of Related Party Transactions for the half year ended 30th June 2020 in the format specified in the relevant Accounting Standard, in terms of Regulation 23(9) of Listing Regulations.NESTLE INDIA LTD. - 500790 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Nestle India Limited-Details of duplicate shares issued on 19th August,2020.Sandip Sabharwal's 2 stock ideas for short and long term
For new investors, there could be risk in something like Britannia or Nestle.'Nestle India to support 10,000 street food vendors
Nestl India on Thursday announced the launch of Maggi Desh Ke liye 2 Minute Ek Chhoti Si Koshish, which will include a year-long initiatives to aNESTLE INDIA LTD. - 500790 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Nestle India Limited has submitted a copy of the Press Release dated 13th August 2020 titled 'Nestle India Launches 'MAGGI -Desh Ke Liye 2 Minute - Ek Chhoti Si Koshish'.Reduce Nestle India; target of Rs 16813: Dolat Capital
Dolat Capital recommended reduce rating on Nestle India with a target price of Rs 16813 in its research report dated July 29, 2020.Reduce Nestle India; target of Rs 14,089: Prabhudas Lilladher
Prabhudas Lilladher recommended reduce rating on Nestle India with a target price of Rs 14,089 in its research report dated July 28, 2020.Nestle India share price slips over 3% on Q1 earnings
Nestle India share is trading higher 100 and 200-day moving averages but lower than 5, 20 and 50-day moving averages. Nestle India stock price has fallen 3% in one week and 0.83% in one month